US Stock MarketDetailed Quotes

ADPT Adaptive Biotechnologies

Watchlist
  • 6.500
  • -0.190-2.84%
Close Jan 10 16:00 ET
  • 6.190
  • -0.310-4.77%
Pre 08:06 ET
959.27MMarket Cap-4.85P/E (TTM)

Adaptive Biotechnologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Adaptive Biotechnologies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 46.490M--
--2024/Q4-- / 46.151M--
Nov 7, 20242024/Q346.435M / 40.229M--
Aug 1, 20242024/Q243.190M / 39.388M--
May 7, 20242024/Q141.873M / 38.780M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 46.490M--
--2024/Q4-- / 46.151M--
Nov 7, 20242024/Q346.435M / 40.229M--
Aug 1, 20242024/Q243.190M / 39.388M--
May 7, 20242024/Q141.873M / 38.780M--

Unlock Free Earnings Estimates

Adaptive Biotechnologies Earnings Reports

  • Adaptive Biotechnologies | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 16:38 ET

  • Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports Third Quarter 2024 Financial Results

    Nov 7, 2024 16:24 ET

  • Adaptive Biotechnologies | 10-Q: Q2 2024 Earnings Report

    Aug 1, 2024 16:32 ET

  • Adaptive Biotechnologies | 8-K: Adaptive Biotechnologies Reports Second Quarter 2024 Financial Results

    Aug 1, 2024 16:20 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 31, 2024

    Buy

    • Buy

      71.43%

    • Hold

      28.57%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data